Skip to main content

Table 3 The association between Tob-1 expression and clinicopathological characteristics of studied colonic lesions

From: The association of p21, inhibin, and Tob-1 expression with the clinicopathological characteristics of benign and malignant colorectal lesions

Variables

Inhibin expression

Positive no. (%)

Negative no. (%)

p-value

Age (in years)

56.84 ± 12.19

50.48 ± 18.148

0.024

Age categories

 

 ≤ 50 years (45)

12 (26.7)

33 (73.3)

0.026

 > 50 years (95)

43 (45.3)

52 (54.7)

Sex

 Female (61)

23 (37.7)

38 (62.3)

0.44

 Male (79)

32 (40.5)

47 (59.5)

CRC (30)

25 (83.3)

5 (16.7)

 

Type of cancer

 Conventional (21)

16 (76.2)

5 (23.8)

0.14

 Mucinous (9)

9 (100)

0

Grade

 Low-grade CRC (13)

10 (77)

3 (23)

0.37

 High-grade CRC (17)

15 (88.2)

2 (11.8)

Adenomas (30)

18 (60)

12 (40)

0.04*

 LGD (14)

6 (43)

8 (57)

0.78

 HGD (16)

12 (75)

4 (25)

UC (30)

9 (30)

21 (70)

0.001*

 No dysplasia (23)

4 (17.4)

19 (82.6)

0.01

 With dysplasia (7)

5 (71.4)

2 (28.6)

Chronic colitis (30)

3 (10)

27 (90)

0.001*

Control (20)

0

20 (100)

0.001*

Total = 140

55 (39.3%)

85 (60.7)

 
  1. LGD low-grade dysplasia, HGD high-grade dysplasia, UC ulcerative colitis, CRC Colorectal cancer, no. number of cases, %; percentage
  2. *p-value compared to CRCs